These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK. Benedict A; Verdian L; Maclaine G Pharmacoeconomics; 2010; 28(3):185-99. PubMed ID: 20151724 [TBL] [Abstract][Full Text] [Related]
23. Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience. Coppola G; Grosso S; Franzoni E; Veggiotti P; Zamponi N; Parisi P; Spalice A; Habetswallner F; Fels A; Capovilla G; Verrotti A; Mangano S; Balestri A; Curatolo P; Pascotto A Seizure; 2010 Nov; 19(9):587-91. PubMed ID: 20888268 [TBL] [Abstract][Full Text] [Related]
24. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
25. Lennox-Gastaut syndrome: a comprehensive review. Asadi-Pooya AA Neurol Sci; 2018 Mar; 39(3):403-414. PubMed ID: 29124439 [TBL] [Abstract][Full Text] [Related]
26. Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data. Kothare S; Kluger G; Sachdeo R; Williams B; Olhaye O; Perdomo C; Bibbiani F Seizure; 2017 Apr; 47():25-33. PubMed ID: 28284045 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of rufinamide in childhood refractory epilepsy. Yıldız EP; Hızlı Z; Bektaş G; Ulak-Özkan M; Tatlı B; Aydınlı N; Çalışkan M; Özmen M Turk J Pediatr; 2018; 60(3):238-243. PubMed ID: 30511535 [TBL] [Abstract][Full Text] [Related]
29. Medical management of Lennox-Gastaut syndrome. Michoulas A; Farrell K CNS Drugs; 2010 May; 24(5):363-74. PubMed ID: 20158289 [TBL] [Abstract][Full Text] [Related]
30. Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy). Kluger G; Bauer B Neuropsychiatr Dis Treat; 2007 Feb; 3(1):3-11. PubMed ID: 19300535 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of rufinamide in pediatric epilepsy. Hsieh DT; Thiele EA Ther Adv Neurol Disord; 2013 May; 6(3):189-98. PubMed ID: 23634191 [TBL] [Abstract][Full Text] [Related]
35. Rufinamide: a new antiepileptic drug treatment for Lennox-Gastaut syndrome. Ferrie CD Expert Rev Neurother; 2010 Jun; 10(6):851-60. PubMed ID: 20518600 [TBL] [Abstract][Full Text] [Related]
36. Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome. Kim SH; Eun SH; Kang HC; Kwon EJ; Byeon JH; Lee YM; Lee JS; Eun BL; Kim HD Seizure; 2012 May; 21(4):288-91. PubMed ID: 22421185 [TBL] [Abstract][Full Text] [Related]
37. How Can an Na Lin YC; Lai YC; Chou P; Hsueh SW; Lin TH; Huang CS; Wang RW; Yang YC; Kuo CC Ann Neurol; 2021 Jun; 89(6):1099-1113. PubMed ID: 33745195 [TBL] [Abstract][Full Text] [Related]
38. Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines. Coppola G; Besag F; Cusmai R; Dulac O; Kluger G; Moavero R; Nabbout R; Nikanorova M; Pisani F; Verrotti A; von Stülpnagel C; Curatolo P Eur J Paediatr Neurol; 2014 Nov; 18(6):685-90. PubMed ID: 24929673 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea. Lee EH; Yum MS; Ko TS Clin Neurol Neurosurg; 2013 Jul; 115(7):926-9. PubMed ID: 23083943 [TBL] [Abstract][Full Text] [Related]
40. Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review. Balagura G; Riva A; Marchese F; Verrotti A; Striano P Neuropsychiatr Dis Treat; 2020; 16():369-379. PubMed ID: 32103957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]